Pharmaceutical Deviation and Non-Conformance Investigation Checklist
Systematic deviation investigation protects product quality and patient safety. This checklist guides thorough investigation of production deviations, laboratory errors, and quality events per FDA 21 CFR 211.192 requirements.
- Industry: Pharmaceutical
- Frequency: Per Deviation Event
- Estimated Time: 30-60 minutes
- Role: QA Manager / Production Supervisor
- Total Items: 31
- Compliance: FDA 21 CFR 211.192 - Production Record Review and Unexplained Discrepancies, FDA Guidance for Industry - Investigating Out-of-Specification Test Results (2006), EU GMP Chapter 8 - Complaints, Quality Defects and Product Recalls, ICH Q10 Section 3.1.1 Pharmaceutical Quality System Elements
Event Description and Containment
Document the deviation event and immediate containment.
- Deviation event fully described: what, when, where, who discovered, and by whom?
- Immediate containment actions taken and documented?
- Affected batch placed on hold pending investigation outcome?
- Scope of potential impact (which batches, products, equipment) determined?
- Required notifications made to QA, production management, and other stakeholders?
Root Cause Investigation
Document root cause analysis.
- All relevant data and evidence gathered and preserved?
- Timeline of events created?
- Systematic RCA tool applied (5-Why, Fishbone, FMEA, FTA)?
- Root cause hypotheses systematically tested and eliminated?
- Other products, processes, or areas potentially affected assessed?
Product Quality Impact Assessment
Assess impact on product quality and patient safety.
- Impact on Critical Quality Attributes (CQAs) assessed?
- Additional testing or analysis performed to characterize quality impact?
- Impact on product stability assessed?
- Patient safety risk from deviation evaluated?
- Retained samples tested for additional characterization?
Batch Disposition
Document batch disposition decision.
- Batch disposition (approve, reject, hold) justified with documented rationale?
- QA (and QP for EU) approval obtained for disposition decision?
- Other potentially impacted batches assessed for disposition?
- Product recall assessment completed if distributed product affected?
- Regulatory notification requirement (Field Alert, MDR, expedited report) assessed?
CAPA and Prevention
Document corrective and preventive actions.
- CAPA initiated with actions addressing identified root cause?
- SOP revision initiated if process gap contributed to deviation?
- Retraining action initiated if human error involved?
- Engineering or systemic controls considered to prevent recurrence?
- Effectiveness check scheduled for CAPA?
Closure and Reporting
Close investigation with complete documentation.
- Investigation closed within required timeframe per procedure?
- Batch record updated with deviation number and reference?
- Complete investigation report with all evidence documented?
- Deviation data captured for Annual Product Quality Review (APQR)?
- Regulatory notification submitted if required?
- Investigation report signed by QA and relevant department heads?
Related Pharmaceutical Life Sciences Checklists
- Pharmaceutical Data Integrity and ALCOA Plus Compliance Checklist
- Pharmaceutical Change Control Review and Approval Checklist
- Pharmaceutical CAPA Review and Effectiveness Check Checklist
- Pharmaceutical Data Integrity and ALCOA+ Compliance Audit Checklist
- Pharmaceutical QC Laboratory Inspection Checklist
- Pharmaceutical Microbiological Contamination Testing Checklist
- Pharmaceutical Water System Inspection Checklist
- Pharmaceutical Supplier Qualification Audit Checklist
Related Quality Systems Checklists
- Pharmaceutical CAPA Review and Effectiveness Check Checklist - FREE Download
- Pharmaceutical Data Integrity and ALCOA+ Compliance Audit Checklist - FREE Download
- CAPA Review and Effectiveness Verification Checklist - FREE Download
- Pharmaceutical Data Integrity and ALCOA Plus Compliance Checklist - FREE Download
- Pharmaceutical Change Control Review and Approval Checklist - FREE Download
Why Use This Pharmaceutical Deviation and Non-Conformance Investigation Checklist?
This pharmaceutical deviation and non-conformance investigation checklist helps pharmaceutical teams maintain compliance and operational excellence. Designed for qa manager / production supervisor professionals, this checklist covers 31 critical inspection points across 6 sections. Recommended frequency: per deviation event.
Ensures compliance with FDA 21 CFR 211.192 - Production Record Review and Unexplained Discrepancies, FDA Guidance for Industry - Investigating Out-of-Specification Test Results (2006), EU GMP Chapter 8 - Complaints, Quality Defects and Product Recalls, ICH Q10 Section 3.1.1 Pharmaceutical Quality System Elements. Regulatory-aligned for audit readiness and inspection documentation.
Frequently Asked Questions
What is a Pharmaceutical Deviation and Non-Conformance Investigation Checklist?
A Pharmaceutical Deviation and Non-Conformance Investigation Checklist is a standardized inspection form used by qa manager / production supervisor to ensure consistent pharmaceutical operations. It contains 39 inspection points organized into 6 sections. FREE pharmaceutical deviation checklist PDF. Pharmaceutical deviation and non-conformance investigation covering event description, product impact assessment, root cause analysis, batch disposition, regulatory notification assessment, and FDA 21 CFR 211.192 production record review deviation requirements. Download FREE digital template now.
How often should I use this pharmaceutical checklist?
This checklist is designed to be completed per deviation event. Regular use ensures compliance with FDA 21 CFR 211.192 - Production Record Review and Unexplained Discrepancies and FDA Guidance for Industry - Investigating Out-of-Specification Test Results (2006) and helps identify issues before they become problems.
Can I download this Pharmaceutical Deviation and Non-Conformance Investigation Checklist as a PDF?
Yes, you can download this checklist as a FREE PDF for printing or offline use. The checklist includes 39 fields across 6 sections and typically takes 30-60 minutes to complete.
What compliance standards does this checklist cover?
This checklist helps ensure compliance with FDA 21 CFR 211.192 - Production Record Review and Unexplained Discrepancies, FDA Guidance for Industry - Investigating Out-of-Specification Test Results (2006), EU GMP Chapter 8 - Complaints, Quality Defects and Product Recalls, ICH Q10 Section 3.1.1 Pharmaceutical Quality System Elements. Following these standards protects your organization and ensures best practices.
How do I complete this pharmaceutical inspection checklist?
Begin by completing the header fields for Facility Name, Deviation Date and Time, Lead Investigator Name, and Batch Number (if applicable). Work through each of the 6 sections, marking items Yes or No as applicable. Finally, complete the footer fields and add your signature. The entire process takes approximately 30 to 60 minutes.
What are the key sections in this pharmaceutical checklist?
This pharmaceutical checklist is organized into 6 key sections: Event Description and Containment, Root Cause Investigation, Product Quality Impact Assessment, Batch Disposition, CAPA and Prevention, Closure and Reporting. Each section contains specific inspection points that qa manager / production supervisor must verify. The structured layout ensures nothing is missed during pharmaceutical inspections and makes the process efficient, typically taking 30-60 minutes to complete.
Who should use this Pharmaceutical Deviation and Non-Conformance Investigation Checklist?
This checklist is primarily designed for qa manager / production supervisor working in pharmaceutical operations. However, it is also valuable for quality assurance teams, safety officers, compliance managers, and supervisors who need to verify that pharmaceutical standards are being met. Organizations of all sizes can benefit from using this Pharmaceutical Deviation and Non-Conformance Investigation Checklist to maintain consistency and accountability.